{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:00:28Z","timestamp":1789581628764,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11596-026-00174-z","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:18:45Z","timestamp":1772785125000},"page":"332-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trehalose: A Promising Therapeutic Agent for Diverse Pathological Conditions"],"prefix":"10.1007","volume":"46","author":[{"given":"Mahboobeh Ghasemzadeh","family":"Rahbardar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-769X","authenticated-orcid":false,"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"174_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106373","volume":"183","author":"AB Pupyshev","year":"2022","unstructured":"Pupyshev AB, Klyushnik TP, Akopyan AA, et al. Disaccharide trehalose in experimental therapies for neurodegenerative disorders: Molecular targets and translational potential. Pharmacol Res. 2022;183:106373.","journal-title":"Pharmacol Res."},{"key":"174_CR2","doi-asserted-by":"crossref","unstructured":"Crowe JH. Trehalose as a \u201cchemical chaperone\u201d. Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks. New York, NY: Springer New York, 2007:143\u2013158.","DOI":"10.1007\/978-0-387-39975-1_13"},{"issue":"4","key":"174_CR3","doi-asserted-by":"publisher","first-page":"17R","DOI":"10.1093\/glycob\/cwg047","volume":"13","author":"AD Elbein","year":"2003","unstructured":"Elbein AD, Pan YT, Pastuszak I, et al. New insights on trehalose: a multifunctional molecule. Glycobiology. 2003;13(4):17R\u201327R.","journal-title":"Glycobiology."},{"issue":"1","key":"174_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0968-0004(00)88938-0","volume":"20","author":"JM Thevelein","year":"1995","unstructured":"Thevelein JM, Hohmann S. Trehalose synthase: guard to the gate of glycolysis in yeast? Trends Biochem Sci. 1995;20(1):3\u201310.","journal-title":"Trends Biochem Sci."},{"issue":"5","key":"174_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1097-2765(00)80064-7","volume":"1","author":"MA Singer","year":"1998","unstructured":"Singer MA, Lindquist S. Multiple effects of trehalose on protein folding in vitro and in vivo. Mol Cell. 1998;1(5):639\u2013648.","journal-title":"Mol Cell."},{"issue":"1","key":"174_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/pro.3","volume":"18","author":"NK Jain","year":"2009","unstructured":"Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci. 2009;18(1):24\u201336.","journal-title":"Protein Sci."},{"issue":"2","key":"174_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00344-018-9876-x","volume":"38","author":"F Kosar","year":"2019","unstructured":"Kosar F, Akram NA, Sadiq M, et al. Trehalose: a key organic osmolyte effectively involved in plant abiotic stress tolerance. J Plant Growth Regul. 2019;38(2):606\u2013618.","journal-title":"J Plant Growth Regul."},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuro.2014.07.006","volume":"44","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Chigurupati S, Raymick J, et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson\u2019s disease mouse model. Neurotoxicology. 2014;44:250\u2013262.","journal-title":"Neurotoxicology."},{"issue":"20","key":"174_CR9","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1021\/acs.jpcb.6b02517","volume":"120","author":"C Olsson","year":"2016","unstructured":"Olsson C, Jansson H, Swenson J. The role of trehalose for the stabilization of proteins. J Phys Chem B. 2016;120(20):4723\u20134731.","journal-title":"J Phys Chem B."},{"issue":"5","key":"174_CR10","first-page":"60","volume":"10","author":"E Mari","year":"2020","unstructured":"Mari E, Ricci C, Pieraccini S, et al. Trehalose effect on the aggregation of model proteins into amyloid fibrils. Life (Basel). 2020;10(5):60.","journal-title":"Life (Basel)."},{"issue":"3","key":"174_CR11","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1021\/acsbiomaterials.2c01225","volume":"9","author":"Y Hu","year":"2023","unstructured":"Hu Y, Liu X, Liu F, et al. Trehalose in biomedical cryopreservation\u2013properties, mechanisms, delivery methods, applications, benefits, and problems. ACS Biomater Sci Eng. 2023;9(3):1190\u20131204.","journal-title":"ACS Biomater Sci Eng."},{"issue":"2","key":"174_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cryobiol.2014.08.001","volume":"69","author":"B Stokich","year":"2014","unstructured":"Stokich B, Osgood Q, Grimm D, et al. Cryopreservation of hepatocyte (HepG2) cell monolayers: impact of trehalose. Cryobiology. 2014;69(2):281\u2013290.","journal-title":"Cryobiology."},{"issue":"9","key":"174_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/bph.14623","volume":"176","author":"M Khalifeh","year":"2019","unstructured":"Khalifeh M, Barreto GE, Sahebkar A. Trehalose as a promising therapeutic candidate for the treatment of Parkinson\u2019s disease. Br J Pharmacol. 2019;176(9):1173\u20131189.","journal-title":"Br J Pharmacol."},{"issue":"8","key":"174_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201900195","volume":"42","author":"M Khalifeh","year":"2020","unstructured":"Khalifeh M, Read MI, Barreto GE, et al. Trehalose against Alzheimer\u2019s disease: insights into a potential therapy. Bioessays. 2020;42(8):e1900195.","journal-title":"Bioessays."},{"issue":"12","key":"174_CR15","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"D Heras-Sandoval","year":"2014","unstructured":"Heras-Sandoval D, P\u00e9rez-Rojas JM, Hern\u00e1ndez-Dami\u00e1n J, et al. The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014;26(12):2694\u20132701.","journal-title":"Cell Signal."},{"issue":"7","key":"174_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41419-018-0749-9","volume":"9","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Yoon YS, Lee SJ. Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction. Cell Death Dis. 2018;9(7):712.","journal-title":"Cell Death Dis."},{"issue":"9","key":"174_CR17","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1002\/jcp.26583","volume":"233","author":"K Hosseinpour-Moghaddam","year":"2018","unstructured":"Hosseinpour-Moghaddam K, Caraglia M, Sahebkar A. Autophagy induction by trehalose: Molecular mechanisms and therapeutic impacts. J Cell Physiol. 2018;233(9):6524\u20136543.","journal-title":"J Cell Physiol."},{"issue":"6","key":"174_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3177\/jnsv.62.380","volume":"62","author":"A Mizote","year":"2016","unstructured":"Mizote A, Yamada M, Yoshizane C, et al. Daily intake of trehalose is effective in the prevention of lifestyle-related diseases in individuals with risk factors for metabolic syndrome. J Nutr Sci Vitaminol. 2016;62(6):380\u2013387.","journal-title":"J Nutr Sci Vitaminol."},{"issue":"6","key":"174_CR19","first-page":"1693","volume":"19","author":"S Hashemian","year":"2023","unstructured":"Hashemian S, Shojaei M, Radbakhsh S, et al. The effects of oral trehalose on glycaemia, inflammation, and quality of life in patients with type 2 diabetes: a pilot randomized controlled trial. Arch Med Sci. 2023;19(6):1693\u20131700.","journal-title":"Arch Med Sci."},{"key":"174_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12986-020-00443-1","volume":"17","author":"C Arai","year":"2020","unstructured":"Arai C, Suyama A, Arai S, et al. Trehalose itself plays a critical role on lipid metabolism: Trehalose increases jejunum cytoplasmic lipid droplets which negatively correlated with mesenteric adipocyte size in both HFD-fed trehalase KO and WT mice. Nutr Metab. 2020;17:22.","journal-title":"Nutr Metab."},{"issue":"18","key":"174_CR21","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.2174\/1381612825666190708221539","volume":"25","author":"W Yu","year":"2019","unstructured":"Yu W, Zha W, Peng H, et al. Trehalose protects against insulin resistance-induced tissue injury and excessive autophagy in skeletal muscles and kidney. Curr Pharm Des. 2019;25(18):2077\u20132085.","journal-title":"Curr Pharm Des."},{"issue":"3","key":"174_CR22","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.dsx.2019.05.023","volume":"13","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, Yaribeygi A, Sathyapalan T, et al. Molecular mechanisms of trehalose in modulating glucose homeostasis in diabetes. Diabetes Metab Syndr. 2019;13(3):2214\u20132218.","journal-title":"Diabetes Metab Syndr."},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"118968","DOI":"10.1016\/j.lfs.2020.118968","volume":"269","author":"SN Chaitanya","year":"2021","unstructured":"S N Chaitanya N, Devi A, Sahu S, et al. Molecular mechanisms of action of Trehalose in cancer: a comprehensive review. Life Sci. 2021;269:118968.","journal-title":"Life Sci."},{"issue":"6","key":"174_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2174\/1389203724666230606154719","volume":"24","author":"E Sharma","year":"2023","unstructured":"Sharma E, Shruti PS, Singh S, et al. Trehalose and its diverse biological potential. Curr Protein Pept Sci. 2023;24(6):503\u2013517.","journal-title":"Curr Protein Pept Sci."},{"issue":"4","key":"174_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bbrc.2020.08.037","volume":"532","author":"H Ichihara","year":"2020","unstructured":"Ichihara H, Kuwabara K, Matsumoto Y. Trehalose liposomes induce apoptosis of breast tumor cells in vitro and in vivo. Biochem Biophys Res Commun. 2020;532(4):505\u2013512.","journal-title":"Biochem Biophys Res Commun."},{"key":"174_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112632","volume":"147","author":"T Jamialahmadi","year":"2022","unstructured":"Jamialahmadi T, Emami F, Bagheri RK, et al. The effect of trehalose administration on vascular inflammation in patients with coronary artery disease. Biomedecine Pharmacother. 2022;147:112632.","journal-title":"Biomedecine Pharmacother."},{"issue":"9","key":"174_CR27","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1007\/s10792-021-01869-z","volume":"41","author":"C Cagini","year":"2021","unstructured":"Cagini C, Torroni G, Mariniello M, et al. Trehalose\/sodium hyaluronate eye drops in post-cataract ocular surface disorders. Int Ophthalmol. 2021;41(9):3065\u20133071.","journal-title":"Int Ophthalmol."},{"issue":"17","key":"174_CR28","doi-asserted-by":"publisher","first-page":"e00237","DOI":"10.1128\/JVI.00237-20","volume":"94","author":"P Rawat","year":"2020","unstructured":"Rawat P, Hon S, Teodorof-Diedrich C, et al. Trehalose inhibits human immunodeficiency virus type 1 infection in primary human macrophages and CD4+T lymphocytes through two distinct mechanisms. J Virol. 2020;94(17):e00237\u2013e00220.","journal-title":"J Virol."},{"issue":"6","key":"174_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/OPX.0000000000001086","volume":"94","author":"MM van Tilborg","year":"2017","unstructured":"van Tilborg MM, Murphy PJ, Evans KS. Impact of dry eye symptoms and daily activities in a modern office. Optom Vis Sci. 2017;94(6):688\u2013693.","journal-title":"Optom Vis Sci."},{"issue":"3","key":"174_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/ICO.0000000000001854","volume":"38","author":"M Wu","year":"2019","unstructured":"Wu M, Liu X, Han J, et al. Association between sleep quality, mood status, and ocular surface characteristics in patients with dry eye disease. Cornea. 2019;38(3):311\u2013317.","journal-title":"Cornea."},{"issue":"11","key":"174_CR31","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/S0161-6420(02)01219-8","volume":"109","author":"T Matsuo","year":"2002","unstructured":"Matsuo T, Tsuchida Y, Morimoto N. Trehalose eye drops in the treatment of dry eye syndrome. Ophthalmology. 2002;109(11):2024\u20132029.","journal-title":"Ophthalmology."},{"issue":"4","key":"174_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10384-004-0085-8","volume":"48","author":"T Matsuo","year":"2004","unstructured":"Matsuo T. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Jpn J Ophthalmol. 2004;48(4):321\u2013327.","journal-title":"Jpn J Ophthalmol."},{"key":"174_CR33","first-page":"595","volume":"11","author":"JC Pinto-Bonilla","year":"2015","unstructured":"Pinto-Bonilla JC, Del Olmo-Jimeno A, Llovet-Osuna F, et al. A randomized crossover study comparing trehalose\/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome. Ther Clin Risk Manag. 2015;11:595\u2013603.","journal-title":"Ther Clin Risk Manag."},{"issue":"4","key":"174_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/ICO.0000000000000358","volume":"34","author":"D Schmidl","year":"2015","unstructured":"Schmidl D, Schmetterer L, Witkowska KJ, et al. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease. Cornea. 2015;34(4):421\u2013426.","journal-title":"Cornea."},{"key":"174_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2147\/OPTH.S125203","volume":"11","author":"AJ Mateo Orobia","year":"2017","unstructured":"Mateo Orobia AJ, Casas Pascual P, Crist\u00f3bal Besc\u00f3s J\u00c1, et al. Effects of 3% trehalose as an adjuvant treatment after LASIK. Clin Ophthalmol. 2017;11:347\u2013353.","journal-title":"Clin Ophthalmol."},{"issue":"1","key":"174_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/ejo.5000836","volume":"27","author":"F Chiambaretta","year":"2017","unstructured":"Chiambaretta F, Doan S, Labetoulle M, et al. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome. Eur J Ophthalmol. 2017;27(1):1\u20139.","journal-title":"Eur J Ophthalmol."},{"issue":"8","key":"174_CR37","first-page":"2671","volume":"58","author":"MM Hom","year":"2017","unstructured":"Hom MM, Berdy GJ, Downie LE, et al. Clinical evaluation of a novel lipid-containing lubricant eye drop with omega-3 oil and trehalose. Investigative Ophthalmology & Visual Science. 2017;58(8):2671-2671.","journal-title":"Investigative Ophthalmology & Visual Science."},{"key":"174_CR38","doi-asserted-by":"publisher","first-page":"4691417","DOI":"10.1155\/2018\/4691417","volume":"2018","author":"K Fondi","year":"2018","unstructured":"Fondi K, Wozniak PA, Schmidl D, et al. Effect of hyaluronic acid\/trehalose in two different formulations on signs and symptoms in patients with moderate to severe dry eye disease. J Ophthalmol. 2018;2018:4691417.","journal-title":"J Ophthalmol."},{"key":"174_CR39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2147\/OPTH.S174290","volume":"12","author":"C Fariselli","year":"2018","unstructured":"Fariselli C, Giannaccare G, Fresina M, et al. Trehalose\/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients. Clin Ophthalmol. 2018;12:1293\u20131300.","journal-title":"Clin Ophthalmol."},{"issue":"6","key":"174_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.5935\/0004-2749.20180100","volume":"81","author":"D Ozek","year":"2018","unstructured":"Ozek D, Kemer OE. Effect of the bioprotectant agent trehalose on corneal epithelial healing after corneal cross-linking for keratoconus. Arq Bras Oftalmol. 2018;81(6):505\u2013509.","journal-title":"Arq Bras Oftalmol."},{"issue":"7","key":"174_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jop.2019.0007","volume":"35","author":"A Vagge","year":"2019","unstructured":"Vagge A, Giannaccare G, Traverso CE. Comparison of the efficacy of topical chloramphenicol 0.5%-betamethasone 0.2% (CB) and CB associated with sodium hyaluronate\/trehalose\/carbomer gel following strabismus surgery. J Ocul Pharmacol Ther. 2019;35(7):403\u2013406.","journal-title":"J Ocul Pharmacol Ther."},{"issue":"S263","key":"174_CR42","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1111\/j.1755-3768.2019.5265","volume":"97","author":"K Kaarniranta","year":"2019","unstructured":"Kaarniranta K, J\u00e4rvinen R, Wylegala E, et al. Disease etiology-based design of multifunctional trehalose emulsion eye drops for moderate or severe dry eye: a randomised, quadruple-masked and active-controlled clinical trial. Acta Ophthalmol. 2019;97(S263):5265.","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"174_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jtos.2019.11.004","volume":"18","author":"LE Downie","year":"2020","unstructured":"Downie LE, Hom MM, Berdy GJ, et al. An artificial tear containing flaxseed oil for treating dry eye disease: a randomized controlled trial. Ocul Surf. 2020;18(1):148\u2013157.","journal-title":"Ocul Surf."},{"issue":"1","key":"174_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/15569527.2020.1861001","volume":"40","author":"Y Yildirim","year":"2021","unstructured":"Yildirim Y, Ozsaygili C, Kucuk B. The short term effect of trehalose and different doses of sodium hyaluronate on anterior corneal aberrations in dry eye patients. Cutan Ocul Toxicol. 2021;40(1):14\u201320.","journal-title":"Cutan Ocul Toxicol."},{"issue":"2","key":"174_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/tjo.tjo_58_20","volume":"11","author":"AK Morya","year":"2020","unstructured":"Morya AK, Solanki K, Prakash S, et al. Randomized controlled trial of trehalose: an efficient autophagic bioprotectant in the management of dry eye disease. Taiwan J Ophthalmol. 2020;11(2):161\u2013167.","journal-title":"Taiwan J Ophthalmol."},{"issue":"1","key":"174_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/jop.2020.0104","volume":"37","author":"J Shin","year":"2021","unstructured":"Shin J, Rho CR, Hyon JY, et al. A randomized, placebo-controlled phase II clinical trial of 0.01% or 0.02% cyclosporin A with 3% trehalose in patients with dry eye disease. J Ocul Pharmacol Ther. 2021;37(1):4\u201311.","journal-title":"J Ocul Pharmacol Ther."},{"issue":"11","key":"174_CR47","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/j.jcrs.0000000000000652","volume":"47","author":"C Cagini","year":"2021","unstructured":"Cagini C, Di Lascio G, Torroni G, et al. Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose\/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms. J Cataract Refract Surg. 2021;47(11):1430\u20131435.","journal-title":"J Cataract Refract Surg."},{"issue":"4","key":"174_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.101845","volume":"46","author":"AJ Mateo-Orobia","year":"2023","unstructured":"Mateo-Orobia AJ, Del Prado Sanz E, Blasco-Mart\u00ednez A, et al. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus \u2265 55 years. Cont Lens Anterior Eye. 2023;46(4):101845.","journal-title":"Cont Lens Anterior Eye."},{"issue":"20","key":"174_CR49","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.3390\/jcm12206647","volume":"12","author":"JM S\u00e1nchez-Gonz\u00e1lez","year":"2023","unstructured":"S\u00e1nchez-Gonz\u00e1lez JM, Silva-Viguera C, S\u00e1nchez-Gonz\u00e1lez MC, et al. Tear film stabilization and symptom improvement in dry eye disease: the role of hyaluronic acid and trehalose eyedrops versus carmellose sodium. J Clin Med. 2023;12(20):6647.","journal-title":"J Clin Med."},{"issue":"4","key":"174_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.det.2020.05.002","volume":"38","author":"JM Laudenbach","year":"2020","unstructured":"Laudenbach JM, Kumar SS. Common dental and periodontal diseases. Dermatol Clin. 2020;38(4):413\u2013420.","journal-title":"Dermatol Clin."},{"issue":"3","key":"174_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/geriatrics6030076","volume":"6","author":"AKY Chan","year":"2021","unstructured":"Chan AKY, Tamrakar M, Jiang CM, et al. Common medical and dental problems of older adults: a narrative review. Geriatrics (Basel). 2021;6(3):76.","journal-title":"Geriatrics (Basel)."},{"issue":"6","key":"174_CR52","first-page":"ZE21","volume":"11","author":"RM Baiju","year":"2017","unstructured":"Baiju RM, Peter\u00a0E, Varghese\u00a0NO, et al. Oral health and quality of life: current concepts. J Clin Diagn Res. 2017,11(6):ZE21\u2013ZE26.","journal-title":"J Clin Diagn Res."},{"issue":"9","key":"174_CR53","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijom.2010.04.047","volume":"39","author":"Y Mori","year":"2010","unstructured":"Mori Y, Yano F, Shimohata N, et al. Trehalose inhibits oral dryness by protecting the cell membrane. Int J Oral Maxillofac Surg. 2010;39(9):916\u2013921.","journal-title":"Int J Oral Maxillofac Surg."},{"issue":"3","key":"174_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/JPER.17-0403","volume":"90","author":"AB Kruse","year":"2019","unstructured":"Kruse AB, Akakpo DL, Maamar R, et al. Trehalose powder for subgingival air-polishing during periodontal maintenance therapy: a randomized controlled trial. J Periodontol. 2019;90(3):263\u2013270.","journal-title":"J Periodontol."},{"issue":"1","key":"174_CR55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12903-020-01111-9","volume":"20","author":"AB Kruse","year":"2020","unstructured":"Kruse AB, Maamar R, Akakpo DL, et al. Effects of subgingival air-polishing with trehalose powder on oral biofilm during periodontal maintenance therapy: a randomized-controlled pilot study. BMC Oral Health. 2020;20(1):123.","journal-title":"BMC Oral Health."},{"issue":"1","key":"174_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12903-022-02109-1","volume":"22","author":"AB Kruse","year":"2022","unstructured":"Kruse AB, W\u00f6lki BJ, Woelber JP, et al. Subgingival air polishing with trehalose powder during supportive periodontal therapy: use of a conical shaped tip during a randomized clinical trial. BMC Oral Health. 2022;22(1):70.","journal-title":"BMC Oral Health."},{"key":"174_CR57","doi-asserted-by":"crossref","unstructured":"Lockhart PB, Sun YP. Diseases of the cardiovascular system. Burket's Oral Medicine. 2021:505\u2013552.","DOI":"10.1002\/9781119597797.ch14"},{"issue":"6","key":"174_CR58","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.18632\/aging.100962","volume":"8","author":"RE Kaplon","year":"2016","unstructured":"Kaplon RE, Hill SD, Bispham NZ, et al. Oral trehalose supplementation improves resistance artery endothelial function in healthy middle-aged and older adults. Aging. 2016;8(6):1167\u20131183.","journal-title":"Aging."},{"key":"174_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112632","volume":"147","author":"T Jamialahmadi","year":"2022","unstructured":"Jamialahmadi T, Emami F, Bagheri RK, et al. The effect of trehalose administration on vascular inflammation in patients with coronary artery disease. Biomed Pharmacother. 2022;147:112632.","journal-title":"Biomed Pharmacother."},{"issue":"Supplement_2","key":"174_CR60","doi-asserted-by":"publisher","first-page":"ehac544.2336","DOI":"10.1093\/eurheartj\/ehac544.2336","volume":"43","author":"S Ganjali","year":"2022","unstructured":"Ganjali S, Jamialahmadi T, Banach M, et al. The effect of trehalose administration on miRNA-10a expression in patients with history of myocardial infarction (MI) and systemic inflammation. Eur Heart J. 2022;43(Supplement_2):ehac544.2336.","journal-title":"Eur Heart J."},{"key":"174_CR61","doi-asserted-by":"crossref","unstructured":"Ganjali S, Jamialahmadi T, Abbasifard M, et al. Trehalose-induced alterations in serum expression levels of microRNAs associated with vascular inflammation in patients with coronary artery disease - the pilot results from the randomized controlled trial. Arch Med Sci. 2022:154987.","DOI":"10.5114\/aoms\/154987"},{"key":"174_CR62","doi-asserted-by":"crossref","unstructured":"Ganjali S, Mansouri A, Reiner \u017d, et al. The effect of trehalose administration on the serum expression levels of microRNAs associated with lipid metabolism and autophagy process in patients with myocardial infarction - the post-hoc analysis of the TREAT-IR trial. Arch Med Sci. 2023:170159.","DOI":"10.5114\/aoms\/170159"},{"issue":"6","key":"174_CR63","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/ptr.7406","volume":"36","author":"N Najafi","year":"2022","unstructured":"Najafi N, Mehri S, Ghasemzadeh Rahbardar M, et al. Effects of alpha lipoic acid on metabolic syndrome: a comprehensive review. Phytother Res. 2022;36(6):2300\u20132323.","journal-title":"Phytother Res."},{"issue":"2","key":"174_CR64","first-page":"198","volume":"25","author":"A Ardakanian","year":"2022","unstructured":"Ardakanian A, Ghasemzadeh Rahbardar M, Omidkhoda F, et al. Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats. Iran J Basic Med Sci. 2022;25(2):198\u2013207.","journal-title":"Iran J Basic Med Sci."},{"key":"174_CR65","doi-asserted-by":"publisher","first-page":"115672","DOI":"10.1016\/j.jep.2022.115672","volume":"299","author":"J Jalali","year":"2022","unstructured":"Jalali J, Ghasemzadeh Rahbardar M. Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: a review. J Ethnopharmacol. 2022;299:115672.","journal-title":"J Ethnopharmacol."},{"issue":"11","key":"174_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21844","volume":"9","author":"K Naraki","year":"2023","unstructured":"Naraki K, Ghasemzadeh Rahbardar M, Ajiboye BO, et al. The effect of ellagic acid on the metabolic syndrome: a review article. Heliyon. 2023;9(11):e21844.","journal-title":"Heliyon."},{"issue":"7","key":"174_CR67","first-page":"738","volume":"26","author":"Z Oskouei","year":"2023","unstructured":"Oskouei Z, Ghasemzadeh Rahbardar M, Hosseinzadeh H. The effects of Dendrobium species on the metabolic syndrome: a review. Iran J Basic Med Sci. 2023;26(7):738\u2013752.","journal-title":"Iran J Basic Med Sci."},{"issue":"11","key":"174_CR68","first-page":"1462","volume":"24","author":"R Yahyazadeh","year":"2021","unstructured":"Yahyazadeh R, Ghasemzadeh Rahbardar M, Razavi BM, et al. The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review. Iran J Basic Med Sci. 2021;24(11):1462\u20131469.","journal-title":"Iran J Basic Med Sci."},{"issue":"10397","key":"174_CR69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBDD Collaborators","year":"2023","unstructured":"Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u2013234.","journal-title":"Lancet."},{"issue":"20","key":"174_CR70","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2174\/0113816128302667240422110226","volume":"30","author":"J Liang","year":"2024","unstructured":"Liang J, He Y, Huang C, et al. The regulation of selenoproteins in diabetes: a new way to treat diabetes. Curr Pharm Des. 2024;30(20):1541\u20131547.","journal-title":"Curr Pharm Des."},{"issue":"2","key":"174_CR71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/advances\/nmy084","volume":"10","author":"W Ren","year":"2019","unstructured":"Ren W, Xia Y, Chen S, et al. Glutamine metabolism in macrophages: a novel target for obesity\/type 2 diabetes. Adv Nutr. 2019;10(2):321\u2013330.","journal-title":"Adv Nutr."},{"key":"174_CR72","volume":"42","author":"B Gieroba","year":"2025","unstructured":"Gieroba B, Kryska A, Sroka-Bartnicka A. Type 2 diabetes mellitus\u2013conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep. 2025;42:102037.","journal-title":"Biochem Biophys Rep."},{"issue":"7","key":"174_CR73","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1017\/S0007114511006714","volume":"108","author":"JG van Can","year":"2012","unstructured":"van Can JG, van Loon LJ, Brouns F, et al. Reduced glycaemic and insulinaemic responses following trehalose and isomaltulose ingestion: implications for postprandial substrate use in impaired glucose-tolerant subjects. Br J Nutr. 2012;108(7):1210\u20131217.","journal-title":"Br J Nutr."},{"issue":"1","key":"174_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12937-017-0233-x","volume":"16","author":"C Yoshizane","year":"2017","unstructured":"Yoshizane C, Mizote A, Yamada M, et al. Glycemic, insulinemic and incretin responses after oral trehalose ingestion in healthy subjects. Nutr J. 2017;16(1):9.","journal-title":"Nutr J."},{"issue":"1","key":"174_CR75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12937-020-00586-0","volume":"19","author":"C Yoshizane","year":"2020","unstructured":"Yoshizane C, Mizote A, Arai C, et al. Daily consumption of one teaspoon of trehalose can help maintain glucose homeostasis: a double-blind, randomized controlled trial conducted in healthy volunteers. Nutr J. 2020;19(1):68.","journal-title":"Nutr J."},{"issue":"1","key":"174_CR76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/jcm11010247","volume":"11","author":"M Mobini","year":"2022","unstructured":"Mobini M, Radbakhsh S, Kubaski F, et al. Impact of intravenous trehalose administration in patients with niemann-pick disease types a and B. J Clin Med. 2022;11(1):247.","journal-title":"J Clin Med."},{"key":"174_CR77","doi-asserted-by":"crossref","unstructured":"Khoshakhlagh M, Hasanpour M, Iranshahi M, et al. Metabolic improvement in patients with Niemann-Pick disease following intravenous trehalose administration: An untargeted pharmacometabolomic study. 2023.","DOI":"10.21203\/rs.3.rs-3131527\/v1"},{"issue":"10","key":"174_CR78","first-page":"1166","volume":"25","author":"SA Emadi","year":"2022","unstructured":"Emadi SA, Ghasemzadeh Rahbardar M, Mehri S, et al. A review of therapeutic potentials of milk thistle (Silybum marianum L.) and its main constituent, silymarin, on cancer, and their related patents. Iran J Basic Med Sci. 2022;25(10):1166\u20131176.","journal-title":"Iran J Basic Med Sci."},{"issue":"10","key":"174_CR79","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1002\/ptr.7563","volume":"36","author":"R Rajabalizadeh","year":"2022","unstructured":"Rajabalizadeh R, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Medicinal herbs in treating chemotherapy-induced nausea and vomiting: a review. Phytother Res. 2022;36(10):3691\u20133708.","journal-title":"Phytother Res."},{"issue":"2","key":"174_CR80","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/01635581.2021.1931362","volume":"74","author":"MG Rahbardar","year":"2022","unstructured":"Rahbardar MG, Eisvand F, Rameshrad M, et al. In vivo and in vitro protective effects of rosmarinic acid against doxorubicin-induced cardiotoxicity. Nutr Cancer. 2022;74(2):747\u2013760.","journal-title":"Nutr Cancer."},{"issue":"3","key":"174_CR81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF00205537","volume":"6","author":"G Vosika","year":"1979","unstructured":"Vosika G, Schmidtke J, Goldman A, et al. Phase I\u2013II study of intralesional immunotherapy with oil-attached Mycobacterium smegmatis cell wall skeleton and trehalose dimycolate. Cancer Immunol Immunother. 1979;6(3):135\u2013142.","journal-title":"Cancer Immunol Immunother."},{"issue":"4","key":"174_CR82","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00205470","volume":"7","author":"G Vosika","year":"1980","unstructured":"Vosika G, Schmidtke J, Goldman A, et al. Phase I study of intradermal immunotherapy with oil-attached Mycobacterium smegmatis cell wall skeleton and trehalose dimycolate. Cancer Immunol Immunother. 1980;7(4):221\u2013224.","journal-title":"Cancer Immunol Immunother."},{"issue":"1","key":"174_CR83","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12903-023-02966-4","volume":"23","author":"P Piboonratanakit","year":"2023","unstructured":"Piboonratanakit P, Ferreira JN, Pravinvongvuthi K, et al. Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial. BMC Oral Health. 2023;23(1):288.","journal-title":"BMC Oral Health."},{"issue":"12","key":"174_CR84","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1002\/ptr.7224","volume":"35","author":"BM Razavi","year":"2021","unstructured":"Razavi BM, Ghasemzadeh Rahbardar M, Hosseinzadeh H. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytother Res. 2021;35(12):6489\u20136513.","journal-title":"Phytother Res."},{"key":"174_CR85","doi-asserted-by":"crossref","unstructured":"Nakisa N, Ghasemzadeh Rahbardar M. Action mechanisms of antirheumatic herbal medicines. Rheumatoid Arthritis. London: IntechOpen, 2022.","DOI":"10.5772\/intechopen.99133"},{"issue":"3","key":"174_CR86","first-page":"71","volume":"9","author":"N Nakisa","year":"2022","unstructured":"Nakisa N. Therapeutic potential of rosemary (Rosmarinus officinalis L.) on sports injuries: a review of patents. Res J Pharmacogn. 2022;9(3):71\u201383.","journal-title":"Res J Pharmacogn."},{"issue":"3","key":"174_CR87","volume":"2","author":"A Gobbi","year":"2022","unstructured":"Gobbi A, Morales M, Avio G, et al. Double-blinded prospective randomized clinical trial in knee joint osteoarthritis treatment: safety assessment and performance of trehalose hyaluronic acid versus standard infiltrative therapy based on medium-weight sodium hyaluronate. J Cartil Jt Preserv. 2022;2(3):100043.","journal-title":"J Cartil Jt Preserv."},{"issue":"20","key":"174_CR88","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2174\/0929867330666230406102555","volume":"31","author":"M Mobini","year":"2024","unstructured":"Mobini M, Radbakhsh S, Kubaski F, et al. Effects of trehalose administration in patients with Mucopolysaccharidosis type III. Curr Med Chem. 2024;31(20):3033\u20133042.","journal-title":"Curr Med Chem."},{"issue":"5","key":"174_CR89","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.5114\/aoms\/159711","volume":"19","author":"S Radbakhsh","year":"2023","unstructured":"Radbakhsh S, Mobini M, Gumpricht E, et al. The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency. Arch Med Sci. 2023;19(5):1564\u20131568.","journal-title":"Arch Med Sci."},{"issue":"8","key":"174_CR90","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/03007995.2018.1434496","volume":"34","author":"S Doan","year":"2018","unstructured":"Doan S, Bremond-Gignac D, Chiambaretta F. Comparison of the effect of a hyaluronate-trehalose solution to hyaluronate alone on Ocular Surface Disease Index in patients with moderate to severe dry eye disease. Curr Med Res Opin. 2018;34(8):1373\u20131376.","journal-title":"Curr Med Res Opin."},{"issue":"10","key":"174_CR91","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s10792-021-01897-9","volume":"41","author":"S Brar","year":"2021","unstructured":"Brar S, Vanga HR, Ganesh S. Comparison of efficacy of trehalose-based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non-invasive investigational modalities. Int Ophthalmol. 2021;41(10):3349\u20133359.","journal-title":"Int Ophthalmol."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-026-00174-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-026-00174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:06:23Z","timestamp":1777388783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-026-00174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1007\/s11596-026-00174-z","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}